DT Axis Inc.'s medical device program 'Lifton D®' has been designated for evaluation therapy. The app aims to alleviate symptoms in patients with moderate to severe depression who do not respond sufficiently to medication. Evaluation therapy is a system intended to pave the way for future insurance coverage; usage requires procedures at medical institutions, and costs are borne by the patient. The program runs until May 31, 2030.

FACT BOX

  • Source: PR TIMES
  • Category: medical_regulation